New York State Common Retirement Fund’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-76,294
| Closed | -$3.59M | – | 3229 |
|
|
2025
Q2 | $3.59M | Sell |
76,294
-289,566
| -79% | -$12.9M | ﹤0.01% | 1202 |
|
|
2025
Q1 | $16.1M | Buy |
365,860
+1,800
| +0.5% | +$82.9K | 0.02% | 519 |
|
|
2024
Q4 | $13.2M | Hold |
364,060
| – | – | 0.02% | 637 |
|
|
2024
Q3 | $11.7M | Buy |
364,060
+6,717
| +2% | +$251K | 0.02% | 706 |
|
|
2024
Q2 | $13.5M | Buy |
357,343
+103,640
| +41% | +$4.36M | 0.02% | 670 |
|
|
2024
Q1 | $12.5M | Sell |
253,703
-38
| -0% | -$1.76K | 0.02% | 724 |
|
|
2023
Q4 | $9.26M | Buy |
253,741
+3,987
| +2% | +$104K | 0.01% | 858 |
|
|
2023
Q3 | $5.77M | Buy |
249,754
+336
| +0.1% | +$9.19K | 0.01% | 1044 |
|
|
2023
Q2 | $6.54M | Buy |
249,418
+65,872
| +36% | +$1.73M | 0.01% | 1053 |
|
|
2023
Q1 | $4.72M | Sell |
183,546
-6,188
| -3% | -$181K | 0.01% | 1191 |
|
|
2022
Q4 | $4.93M | Sell |
189,734
-18,901
| -9% | -$466K | 0.01% | 1188 |
|
|
2022
Q3 | $5.95M | Buy |
208,635
+18,985
| +10% | +$544K | 0.01% | 1077 |
|
|
2022
Q2 | $4.67M | Buy |
189,650
+3,972
| +2% | +$145K | 0.01% | 1229 |
|
|
2022
Q1 | $10.5M | Sell |
185,678
-3
| -0% | -$172 | 0.01% | 938 |
|
|
2021
Q4 | $11.5M | Buy |
185,681
+84,052
| +83% | +$5.56M | 0.01% | 934 |
|
|
2021
Q3 | $6.45M | Buy |
101,629
+76,341
| +302% | +$5.88M | 0.01% | 1201 |
|
|
2021
Q2 | $2.08M | Buy |
25,288
+2,888
| +13% | +$219K | ﹤0.01% | 1840 |
|
|
2021
Q1 | $1.65M | Buy |
22,400
+1,500
| +7% | +$117K | ﹤0.01% | 1895 |
|
|
2020
Q4 | $1.52M | Buy |
20,900
+1,400
| +7% | +$90.1K | ﹤0.01% | 1822 |
|
|
2020
Q3 | $930K | Hold |
19,500
| – | – | ﹤0.01% | 1941 |
|
|
2020
Q2 | $819K | Buy |
19,500
+10,100
| +107% | +$359K | ﹤0.01% | 1972 |
|
|
2020
Q1 | $254K | Hold |
9,400
| – | – | ﹤0.01% | 2344 |
|
|
2019
Q4 | $362K | Buy |
+9,400
| New | +$220K | ﹤0.01% | 2453 |
|
Other funds holding SWTX
New York State Common Retirement Fund's SWTX Position: Q3 2025 in Review
New York State Common Retirement Fund sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 76,294 shares — an estimated $3.59M sold.
New York State Common Retirement Fund first reported a position in SWTX in Q4 2019 and held it in 23 quarters. The position peaked at $16.1M in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- New York State Common Retirement Fund reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- New York State Common Retirement Fund sold 76,294 SpringWorks Therapeutics shares in Q3 2025, an estimated $3.59M.
- New York State Common Retirement Fund first reported a position in SpringWorks Therapeutics in Q4 2019 and held it in 23 quarters.
- New York State Common Retirement Fund's SpringWorks Therapeutics position peaked at $16.1M in Q1 2025.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on New York State Common Retirement Fund's 13F filing for Q3 2025, filed 3 Nov 2025.